Summary of Mona Mae’s Ongoing Health Journey 1/7/2021 - Journal Entries give more details of our learnings along the way.
4/26/2020 Lump in breast noticed 5/7/2020 Breast cancer confirmed - Invasive Lobular Carcinoma of the Left Breast (Hormone Receptor Positive HER-2 Negative, grade 2 of 3, Ki-67 of 24%) Prepared for left mastectomy Blood tests showed very low White Blood Cells (WBC) 6/1/2020 Bone Marrow Biopsy 6/4/2020 Confirmed AML diagnosis 6/8/2020 Left Breast Mastectomy + 4 Sentinel Nodes 6/18/2020 AML complex karyotype, IDH2 172 mutation positive confirmed 6/24/2020 Treatment Plan Oral chemo (Venetoclax) and Injectable chemo (Azacitidine) Cycle 1 (4 Weeks-7 Days Injections/28 Days Oral) 7/27/2020 Cycle 2 (4 Weeks-7 Days Injections/28 Days Oral) 8/18/2020 Bone Marrow Biopsy 8/24/2020 REMISSION determine via bone marrow biopsy results 9/28/2020 Cycle 3 (2 Weeks-5 Days Injections/14 Days Oral) 11/9/2020 Cycle 4 (2 Weeks-5 Days Injections/14 Days Oral) 11/16/2020 Breast Biopsy on lumps - negative (non-cancer). Determined to be fat-like cells due to mastectomy healing process. 1/4/2021 Cycle 5 (2 Weeks-3 Days Injections/14 Days Oral) 2/15/2021 Cycle 6 (2 Weeks-3 Days Injections/14 Days Oral) 3/29/2021 Cycle 7 (2 Weeks-3 Days Injections/14 Days Oral) 5/10/2021 Cycle 8 (2 Weeks-3 Days Injections/14 Days Oral) Blood is so stable she no longer needs to test in-between Cycles 6/24/2021 Started letrozole (Femara) 2.5mg daily. Waited to start until AML treatments stable and consistent.